PD-1/PD-L1 Inhibitors as Monotherapy in the First-Line Treatment of Advanced Non-Small Cell Lung Cancer Patients with High PD-L1 Expression: An Expert Position Statement

  1. Isla, D.
  2. Sánchez, A.
  3. Casal, J.
  4. Cobo, M.
  5. Majem, M.
  6. Reguart, N.
  7. Zugazagoitia, J.
  8. Bernabé, R.
Revista:
Journal of Clinical Medicine

ISSN: 2077-0383

Ano de publicación: 2023

Volume: 12

Número: 15

Tipo: Artigo

DOI: 10.3390/JCM12155063 GOOGLE SCHOLAR lock_openAcceso aberto editor

Obxectivos de Desenvolvemento Sustentable

Fonte de datos: Scopus